EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report

Kim Dao, Emmannuella Bonègre, Hassib Chehade, Sébastien Lebon

Epilepsy & Behavior Reports · 2026-12 · 36 · 100896

DOI: 10.1016/j.ebr.2026.100896 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Epilepsy & Behavior Reports, 2026-12. Verfasst von Kim Dao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levetiracetam (LEV) is widely used in the treatment of pediatric epilepsy and is typically well tolerated. We hereby present a case involving an infant who exhibited a notable and isolated elevation of alkaline phosphatase (ALP) during a treatment of LEV, with subsequent normalization following drug cessation. Liver function tests and bone turnover markers remained within normal limits, and the patient was asymptomatic. ALP levels returned to normal within four weeks of discontinuing LEV. LEV may cause significant, reversible ALP elevation in children, most likely due to bone origin. Although rare, this potential adverse effect should be considered, particularly during long-term therapy.

Schlagwörter

Stichwörter der Autor:innen

Adverse drug eventCase reportEpilepsyLevetiracetamPediatric

Autor:innen und Institutionen

  • Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Unit of Paediatric Neurology and Neurorehabilitation, Department Mother-Woman-Child, Lausanne University Hospital, and University of Lausanne, Lausanne, Switzerland.
  • Division of Pediatric Nephrology, Department Mother-Woman-Child, Lausanne University Hospital, and University of Lausanne, Lausanne, Switzerland.

Zitieren

APA

Dao, K., Bonègre, E., Chehade, H., & Lebon, S. (2026). Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report. Epilepsy & Behavior Reports, 36, 100896. https://doi.org/10.1016/j.ebr.2026.100896

Vancouver

Dao K, Bonègre E, Chehade H, Lebon S. Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report. Epilepsy & Behavior Reports. 2026;36:100896. doi:10.1016/j.ebr.2026.100896

BibTeX
@article{Dao2026,
  author = {Dao, Kim and Bonègre, Emmannuella and Chehade, Hassib and Lebon, Sébastien},
  title = {Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report},
  journal = {Epilepsy & Behavior Reports},
  year = {2026},
  volume = {36},
  pages = {100896},
  doi = {10.1016/j.ebr.2026.100896}
}
Kostenlos starten →